{"id":"https://openalex.org/W4293109336","doi":"https://doi.org/10.2217/nmt-2022-0019","title":"Relapses in People With Multiple Sclerosis Treated With Cladribine Tablets Followed for Up to 5 Years: A Plain Language Summary","display_name":"Relapses in People With Multiple Sclerosis Treated With Cladribine Tablets Followed for Up to 5 Years: A Plain Language Summary","publication_year":2022,"publication_date":"2022-08-26","ids":{"openalex":"https://openalex.org/W4293109336","doi":"https://doi.org/10.2217/nmt-2022-0019","pmid":"https://pubmed.ncbi.nlm.nih.gov/36017797"},"language":"en","primary_location":{"id":"doi:10.2217/nmt-2022-0019","doi":"https://doi.org/10.2217/nmt-2022-0019","is_oa":true,"landing_page_url":"https://doi.org/10.2217/nmt-2022-0019","pdf_url":null,"source":{"id":"https://openalex.org/S2764766229","display_name":"Neurodegenerative Disease Management","issn_l":"1758-2024","issn":["1758-2024","1758-2032"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurodegenerative Disease Management","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.2217/nmt-2022-0019","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024199819","display_name":"Nicola De Stefano","orcid":"https://orcid.org/0000-0003-4930-7639","observed_orcids":["https://orcid.org/0000-0003-4930-7639"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nicola De Stefano","raw_affiliation_strings":["Department of Neurological & Behavioural Sciences University of Siena Siena Italy/Department of Medicine Surgery & Neuroscience University of Siena\rSiena\rItaly"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurological & Behavioural Sciences University of Siena Siena Italy/Department of Medicine Surgery & Neuroscience University of Siena\rSiena\rItaly","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061993323","display_name":"Maria Pia Sormani","orcid":"https://orcid.org/0000-0001-6892-104X","observed_orcids":["https://orcid.org/0000-0001-6892-104X"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]},{"id":"https://openalex.org/I83816512","display_name":"University of Genoa","ror":"https://ror.org/0107c5v14","country_code":"IT","type":"education","lineage":["https://openalex.org/I83816512"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Pia Sormani","raw_affiliation_strings":["Department of Health Sciences University of Genoa & Ospedale Policlinico San Martino IRCCS\rGenoa\rItaly"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Sciences University of Genoa & Ospedale Policlinico San Martino IRCCS\rGenoa\rItaly","institution_ids":["https://openalex.org/I4210146472","https://openalex.org/I83816512"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015754502","display_name":"Gavin Giovannoni","orcid":"https://orcid.org/0000-0001-9995-1700","observed_orcids":["https://orcid.org/0000-0001-9995-1700"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gavin Giovannoni","raw_affiliation_strings":["Blizard Institute Barts & The London School of Medicine & Dentistry Queen Mary University of London\rLondon\rUK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blizard Institute Barts & The London School of Medicine & Dentistry Queen Mary University of London\rLondon\rUK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049696879","display_name":"Kottil W Rammohan","orcid":"https://orcid.org/0000-0003-2467-4280","observed_orcids":["https://orcid.org/0000-0003-2467-4280"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kottil Rammohan","raw_affiliation_strings":["Department of Neurology, University of Miami School of Medicine, MS Research Center, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University of Miami School of Medicine, MS Research Center, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002866949","display_name":"Thomas P. Leist","orcid":"https://orcid.org/0000-0002-8924-8891","observed_orcids":["https://orcid.org/0000-0002-8924-8891"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas P Leist","raw_affiliation_strings":["Division of Clinical Neuroimmunology, Jefferson University, Comprehensive MS Center, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Neuroimmunology, Jefferson University, Comprehensive MS Center, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012376027","display_name":"Patricia Katherine Coyle","orcid":"https://orcid.org/0000-0002-3801-6177","observed_orcids":["https://orcid.org/0000-0002-3801-6177"]},"institutions":[{"id":"https://openalex.org/I59553526","display_name":"Stony Brook University","ror":"https://ror.org/05qghxh33","country_code":"US","type":"education","lineage":["https://openalex.org/I59553526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia K Coyle","raw_affiliation_strings":["Department of Neurology, Stony Brook University, Stony Brook, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Stony Brook University, Stony Brook, NY, USA","institution_ids":["https://openalex.org/I59553526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010771032","display_name":"Fernando Dangond","orcid":"https://orcid.org/0000-0002-6723-4229","observed_orcids":["https://orcid.org/0000-0002-6723-4229"]},"institutions":[{"id":"https://openalex.org/I4405266695","display_name":"Merck Healthcare KGaA, Darmstadt (Germany)","ror":"https://ror.org/04vpzfb52","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4405266695"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Fernando Dangond","raw_affiliation_strings":["EMD Serono Research & Development Institute Inc. Billerica\rMA\rUSA an affiliate of Merck KGaA","EMD Serono Research & Development Institute Inc., Billerica, MA, USA, an affiliate of Merck KGaA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono Research & Development Institute Inc. Billerica\rMA\rUSA an affiliate of Merck KGaA","institution_ids":["https://openalex.org/I4405266695"]},{"raw_affiliation_string":"EMD Serono Research & Development Institute Inc., Billerica, MA, USA, an affiliate of Merck KGaA","institution_ids":["https://openalex.org/I4405266695"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007546716","display_name":"Nektaria Alexandri","orcid":"https://orcid.org/0000-0002-9806-8358","observed_orcids":["https://orcid.org/0000-0002-9806-8358"]},"institutions":[{"id":"https://openalex.org/I4405266695","display_name":"Merck Healthcare KGaA, Darmstadt (Germany)","ror":"https://ror.org/04vpzfb52","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4405266695"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nektaria Alexandri","raw_affiliation_strings":["Merck Healthcare KGaA, Darmstadt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Healthcare KGaA, Darmstadt, Germany","institution_ids":["https://openalex.org/I4405266695"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048524048","display_name":"Andrew R. Galazka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266695","display_name":"Merck Healthcare KGaA, Darmstadt (Germany)","ror":"https://ror.org/04vpzfb52","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4405266695"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andrew Galazka","raw_affiliation_strings":["Merck Healthcare KGaA, Darmstadt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Healthcare KGaA, Darmstadt, Germany","institution_ids":["https://openalex.org/I4405266695"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.14527591,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"6","first_page":"303","last_page":"310"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9860000014305115},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.6940000057220459},{"id":"https://openalex.org/keywords/cladribine-tablets","display_name":"cladribine tablets","score":0.8790000081062317},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.6710000038146973},{"id":"https://openalex.org/keywords/relapse-severity","display_name":"relapse severity","score":0.6830000281333923},{"id":"https://openalex.org/keywords/long-term-treatment-outcomes","display_name":"long-term treatment outcomes","score":0.6050000190734863},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.7960000038146973}],"concepts":[{"id":"https://openalex.org/C2779200787","wikidata":"https://www.wikidata.org/wiki/Q414030","display_name":"Cladribine","level":2,"score":0.9846846461296082},{"id":"https://openalex.org/C2777146004","wikidata":"https://www.wikidata.org/wiki/Q14949826","display_name":"CLARITY","level":2,"score":0.8663948774337769},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7846369743347168},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.761979341506958},{"id":"https://openalex.org/C81603835","wikidata":"https://www.wikidata.org/wiki/Q3457430","display_name":"Pill","level":2,"score":0.6047345399856567},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.4946841895580292},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4359695315361023},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.2938295602798462},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2503185272216797},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.14662456512451172},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.122550368309021},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06865391135215759},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007802","descriptor_name":"Language","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017338","descriptor_name":"Cladribine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.2217/nmt-2022-0019","doi":"https://doi.org/10.2217/nmt-2022-0019","is_oa":true,"landing_page_url":"https://doi.org/10.2217/nmt-2022-0019","pdf_url":null,"source":{"id":"https://openalex.org/S2764766229","display_name":"Neurodegenerative Disease Management","issn_l":"1758-2024","issn":["1758-2024","1758-2032"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurodegenerative Disease Management","raw_type":"journal-article"},{"id":"pmid:36017797","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36017797","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurodegenerative disease management","raw_type":"Research Support, Non-U.S. Gov't"},{"id":"pmh:oai:iris.unige.it:11567/1095093","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11567/1095093","pdf_url":null,"source":{"id":"https://openalex.org/S4377196291","display_name":"CINECA IRIS Institutial Research Information System (University of Genoa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I83816512","host_organization_name":"University of Genoa","host_organization_lineage":["https://openalex.org/I83816512"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:usiena-air.unisi.it:11365/1282217","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11365/1282217","pdf_url":null,"source":{"id":"https://openalex.org/S4377196319","display_name":"Use Siena air (University of Siena)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I102064193","host_organization_name":"University of Siena","host_organization_lineage":["https://openalex.org/I102064193"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2217/nmt-2022-0019","doi":"https://doi.org/10.2217/nmt-2022-0019","is_oa":true,"landing_page_url":"https://doi.org/10.2217/nmt-2022-0019","pdf_url":null,"source":{"id":"https://openalex.org/S2764766229","display_name":"Neurodegenerative Disease Management","issn_l":"1758-2024","issn":["1758-2024","1758-2032"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurodegenerative Disease Management","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3162840220","https://openalex.org/W2808874540","https://openalex.org/W2588492167","https://openalex.org/W4289517731","https://openalex.org/W2751578374","https://openalex.org/W2774466080","https://openalex.org/W4293109109","https://openalex.org/W2785125944","https://openalex.org/W3188666067","https://openalex.org/W2104301864"],"abstract_inverted_index":{"What":[0,101,175,238],"is":[1,6,82],"this":[2],"summary":[3,8],"about?":[4],"This":[5,60],"a":[7,51,95,142],"of":[9,58,74,97,165,198,249,258],"an":[10,162],"article":[11,20],"originally":[12],"published":[13],"in":[14,39,76,103,141,172,191,212,234,260],"the":[15,22,25,70,104,107,118,127,146,177,192,213,235,240,245,254],"Multiple":[16],"Sclerosis":[17],"Journal.":[18],"The":[19],"presents":[21],"results":[23,241],"from":[24],"CLARITY":[26,28,108,128,147,193,214,236],"and":[27,72,256],"Extension":[29,148,215],"studies,":[30],"which":[31,221],"looked":[32,62],"at":[33,63],"how":[34,64],"well":[35],"cladribine":[36,67,114,135,186,210,232,250],"tablets":[37,49,68,115,136,187,233,251],"work":[38],"treating":[40,55],"people":[41,77,111,261],"with":[42,66,78,180,185,202,262],"multiple":[43],"sclerosis":[44],"(shortened":[45],"to":[46,138,167,225,266],"MS).":[47],"Cladribine":[48],"are":[50],"medication":[52],"approved":[53,119],"for":[54,157,188,223,264],"relapsing":[56],"forms":[57],"MS.":[59,79],"study":[61,129,144,194,216],"treatment":[65],"affects":[69],"frequency":[71],"severity":[73,257],"relapses":[75,259],"A":[80],"relapse":[81,200],"when":[83],"new":[84],"symptoms":[85,89],"develop":[86],"or":[87,91,99,121],"old":[88],"return":[90],"get":[92],"worse":[93],"after":[94,229],"period":[96,164],"stability":[98],"improvement.":[100],"happened":[102],"studies?":[105],"In":[106],"study,":[109],"870":[110],"received":[112,134,231],"either":[113],"(3.5":[116],"mg/kg,":[117],"dose)":[120],"placebo":[122,156,208],"(a":[123],"dummy":[124],"pill).":[125],"After":[126],"ended,":[130],"some":[131],"participants":[132],"who":[133,182],"chose":[137],"take":[139],"part":[140],"second":[143],"called":[145],"study.":[149,174,237],"Of":[150],"these":[151,218],"participants,":[152],"98":[153],"were":[154,176,183],"given":[155,204],"2":[158,189],"more":[159,227],"years":[160,190,228],"following":[161],"interval":[163],"up":[166,224,265],"10":[168],"months":[169],"between":[170],"participating":[171],"each":[173],"results?":[178],"People":[179],"MS":[181,263],"treated":[184],"had":[195],"lower":[196],"risks":[197],"any":[199],"compared":[201],"those":[203],"placebo.":[205],"Participants":[206],"taking":[207],"(after":[209],"tablets)":[211],"experienced":[217],"same":[219],"benefits,":[220],"continued":[222],"3":[226],"having":[230],"do":[239],"mean?":[242],"Researchers":[243],"concluded":[244],"recommended":[246],"2-year":[247],"dosing":[248],"may":[252],"reduce":[253],"number":[255],"5":[267],"years.":[268],"Clinical":[269,274],"Trial":[270,275],"Registration:":[271,276],"NCT00213135":[272],"(ClinicalTrials.gov)":[273,278],"NCT00641537":[277]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-08-26T00:00:00"}